Continuous subcutaneous infusion practices of United States hospices

Journal of Pain and Symptom Management

Volumn 22, Issue 6, 2001, Pages 1027-1034

  Herndon, Christopher M ^a,b   Fike, David S ^b  

^a Ortho McNeil Pharmaceutical Inc   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Clysis; Hospice; Hyaluronidase; Hydromorphone; Hypodermoclysis; Infusion; Morphine; Opioid; Pain; Subcutaneous

Indexed keywords

ATROPINE; CALCITONIN; DEXAMETHASONE; DIAZEPAM; DILUENT; DROPERIDOL; FENTANYL; FUROSEMIDE; HALOPERIDOL; HEPARIN; HYALURONIDASE; HYDROMORPHONE; HYDROXYZINE; KETAMINE; KETOROLAC; LEVOMEPROMAZINE; LORAZEPAM; METOCLOPRAMIDE; MIDAZOLAM; MORPHINE; OCTREOTIDE; PETHIDINE; PHENOBARBITAL; PHENYTOIN; PROMETHAZINE; SCOPOLAMINE; UNINDEXED DRUG;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG USE; HOSPICE; HUMAN; INFUSION; PAIN; PALLIATIVE THERAPY; QUESTIONNAIRE; TECHNIQUE; TERMINAL CARE; UNITED STATES;

ANALGESICS; HOSPICES; HUMANS; INFUSIONS, INTRAVENOUS; PAIN; PHYSICIAN'S PRACTICE PATTERNS; UNITED STATES;

EID: 0035216044     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(01)00365-7     Document Type: Article

References (47)

1. Continuous subcutaneous infusion for pain management
2. The treatment of infantile diarrhea by saline injections
3. The danger of administering parenteral fluids by hypodermoclysis
4. Analgesia in terminal malignant disease
5. Safe, simple subcutaneous fluid administration
6. Subcutaneous fluid infusion (hypodermoclysis) in palliative care: New role for an old trick
7. Hypodermoclysis for the administration of fluids and narcotic analgesics in patients with advanced cancer
8. A randomized, double-blind, double-dummy, crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer pain
9. Hypodermoclysis in dehydrated elderly patients: Local effects with and without hyaluronidase
10. Subcutaneous infusions for control of cancer symptoms
11. Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain
12. A prospective, within-patient, crossover study of continuous intravenous and subcutaneous morphine for chronic cancer pain
13. Subcutaneous narcotic infusions for cancer pain: Treatment outcome and guidelines for use
14. Utility of clysis for hydration in nursing home residents
15. Subcutaneous infusion or hypodermoclysis: A practical approach
16. Subcutaneous fluid administration - Better than the intravenous approach?
17. Nutrition by hypodermoclysis
18. Dehydration in the terminal patient: Perception of hospice nurses
19. Should fluid and nutritional support be withheld from terminally ill patients? Tube feeding in hospice settings
20. Dehydration in dying patients
21. Subcutaneous infusions - A medical last rite
22. Palliative care. Terminal dehydration
23. Terminal dehydration: A review
24. Hydration and alimentation in terminal patients: A hospice approach
25. Ethics forum: Hydration in a dying patient
26. Perceptions and decision-making on rehydration of terminally ill cancer patients and family members
27. Science, hospice, and terminal dehydration
28. Rehydration in palliative care
29. When oral morphine fails in cancer pain: The role of the alternative routes
30. Alternate routes of opioid administration in palliative care: Pharmacologic and clinical concerns
31. Symptom control in advanced cancer: Important drugs and routes of administration
32. Hypodermoclysis as a means of rehydration
33. Palliative medicine in the elderly
34. Hypodermoclysis therapy in a chronic care hospital setting
35. Use of continuous ambulatory infusions of concentrated subcutaneous (SC) hydromorphone versus intravenous (IV) morphine: Cost implications for palliative care
36. A randomized controlled trial of local injections of hyaluronidase versus placebo in cancer patients receiving subcutaneous hydration
37. A systematic review of the evidence for hypodermoclysis to treat dehydration in older people
38. Pharmacologic treatment of cancer pain
39. Hypodermoclysis
40. Hypodermoclysis in the home
41. Hypodermoclysis revisited
42. Advantages of hypodermoclysis
43. Performance of a restrictive flow device and an electronic syringe driver for continuous subcutaneous infusion
44. Hypodermoclysis (HDC) for symptom control vs. the Edmonton Injector (EI)
45. Subcutaneous hydration by hypodermoclysis. A practical and low cost treatment for elderly patients